AEVIS (AEVIS) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
26 May, 2026Executive summary
Achieved total revenues of CHF 761.0 million as at 30 September 2024, up 7.1% year-over-year.
Organic revenue growth reached 6.0%, reflecting solid performance across healthcare, hospitality, and real estate.
Financial highlights
Total revenues increased to CHF 761.0 million from CHF 710.2 million year-over-year.
Organic revenue growth was 6.0% for the nine-month period.
Segment performance
Healthcare segment (Swiss Medical Network SA) generated CHF 594.9 million, up 5.1% year-over-year, with 3.7% organic growth.
Hospitality division (MRH Switzerland AG) posted CHF 151.6 million, up 12.4% year-over-year, with 11.7% organic growth, driven by Interlaken and Zermatt.
Real estate segment reported CHF 24.0 million, a 24.8% increase year-over-year, benefiting from asset appreciation.
Latest events from AEVIS
- Acquisition for CHF 50M in shares and CHF 70M debt drives CHF 100M revenue boost in 2025.AEVIS
M&A announcement26 May 2026 - Revenue up 13.5% to CHF 1,055.1m, with deleveraging and margin improvement across segments.AEVIS
H2 202526 May 2026 - Revenue and EBITDAR surged, with net profit rebounding and strong segment growth.AEVIS
H1 202426 May 2026 - Net profit surged to CHF 26.5m, with robust growth and improved capital strength.AEVIS
H2 202426 May 2026 - Q1 2025 revenue rose 17.0% year-over-year, led by healthcare and hospitality growth.AEVIS
Q1 202526 May 2026 - H1-2025 saw revenue up 17.9%, strong margins, and debt cut by over CHF 120m.AEVIS
H1 202526 May 2026 - Revenue up 18.2% year-over-year, with strong growth in Healthcare, Hospitality, and Real Estate.AEVIS
Q3 202526 May 2026 - Q1 2026 saw strong growth in rental income and profitability, with robust outlook for the year.AEVIS
Q1 202626 May 2026